Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2014

01.02.2014 | Retinal Disorders

Repeatability of visual function measures in age-related macular degeneration

verfasst von: Tariq Aslam, Sajjad Mahmood, Konstantinos Balaskas, Niall Patton, Rajeev G. Tanawade, Shi Zhuan Tan, Stephen A. Roberts, Jeremy Parkes, Paul N. Bishop

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess repeatability of visual function measures in patients with early, intermediate or late age-related macular degeneration (AMD) without active neovascular disease in the study eye, but active neovascular AMD in the fellow eye.

Methods

One hundred subjects from an ongoing trial were screened for this study in which their LogMAR acuity, contrast sensitivity and reading performance were assessed using standardised protocols by trained optometrists. The same measures were repeated one month later and repeatability of the visual functions assessed.

Results

Data from 83 subjects satisfied inclusion criteria for analysis. Coefficient of repeatability was 14.9 letters for LogMAR visual acuity , 7.2 letters for Pelli Robson contrast sensitivity, 0.72 for LogMAR reading acuity, 110.4 words/ min for reading speed and 0.67 for LogMAR critical print size. Intraclass correlation coefficients allowed comparison between measures and were found to be 0.96 for LogMAR visual acuity, 0.93 for contrast sensitivity, 0.75 for LogMAR reading acuity, 0.79 for reading speed and 0.74 for LogMAR critical print size. Coefficients of variation were 9.4 %, 10.7 %, 48.4 %, 28.4 % and 31.8 % respectively.

Conclusions

We found coefficients of repeatability that concurred with previous studies demonstrating variability of visual functions in patients with AMD. In addition, we found intraclass correlation coefficients to be better with visual acuity and contrast sensitivity than with measures of reading performance.
Literatur
1.
Zurück zum Zitat Arditi A, Cagenello R (1993) On the statistical reliability of letter-chart visual acuity measurements. Invest Ophthalmol Vis Sci 34:120–129PubMed Arditi A, Cagenello R (1993) On the statistical reliability of letter-chart visual acuity measurements. Invest Ophthalmol Vis Sci 34:120–129PubMed
2.
Zurück zum Zitat Klein R, Wang Q, Klein BE, Moss SE, Meuer SM (1995) The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36:182–191PubMed Klein R, Wang Q, Klein BE, Moss SE, Meuer SM (1995) The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36:182–191PubMed
3.
Zurück zum Zitat Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148:43–58PubMedCrossRef Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148:43–58PubMedCrossRef
4.
Zurück zum Zitat Neelam K, Nolan J, Chakravarthy U, Beatty S (2009) Psychophysical function in age-related maculopathy. Surv Ophthalmol 54:167–210PubMedCrossRef Neelam K, Nolan J, Chakravarthy U, Beatty S (2009) Psychophysical function in age-related maculopathy. Surv Ophthalmol 54:167–210PubMedCrossRef
5.
Zurück zum Zitat Rosser DA, Cousens SN, Murdoch IE, Fitzke FW, Laidlaw DA (2003) How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci 44:3278–3281PubMedCrossRef Rosser DA, Cousens SN, Murdoch IE, Fitzke FW, Laidlaw DA (2003) How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci 44:3278–3281PubMedCrossRef
6.
Zurück zum Zitat Midena E, Angeli CD, Blarzino MC, Valenti M, Segato T (1997) Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 38:469–475PubMed Midena E, Angeli CD, Blarzino MC, Valenti M, Segato T (1997) Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 38:469–475PubMed
7.
Zurück zum Zitat Rubin GS, Turano K (1994) Low vision reading with sequential word presentation. Vision Res 34:1723–1733PubMedCrossRef Rubin GS, Turano K (1994) Low vision reading with sequential word presentation. Vision Res 34:1723–1733PubMedCrossRef
8.
Zurück zum Zitat Sunness JS, Applegate CA, Haselwood D, Rubin GS (1996) Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 103:1458–1466PubMedCentralPubMedCrossRef Sunness JS, Applegate CA, Haselwood D, Rubin GS (1996) Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 103:1458–1466PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Patel PJ, Chen FK, Da Cruz L, Rubin GS, Tufail A, ABC Trial Study Group (2011) Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 52:3089–3093PubMedCrossRef Patel PJ, Chen FK, Da Cruz L, Rubin GS, Tufail A, ABC Trial Study Group (2011) Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 52:3089–3093PubMedCrossRef
10.
Zurück zum Zitat Patel PJ, Bunce C, Tufail A (2008) A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(R) (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design. Trials 9:56PubMedCentralPubMedCrossRef Patel PJ, Bunce C, Tufail A (2008) A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(R) (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design. Trials 9:56PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Patel PJ, Chen FK, Rubin GS, Tufail A (2008) Intersession repeatability of visual acuity scores in age-related macular degeneration. Invest Ophthalmol Vis Sci 49:4347–4352PubMedCrossRef Patel PJ, Chen FK, Rubin GS, Tufail A (2008) Intersession repeatability of visual acuity scores in age-related macular degeneration. Invest Ophthalmol Vis Sci 49:4347–4352PubMedCrossRef
12.
Zurück zum Zitat Patel PJ, Chen FK, Rubin GS, Tufail A (2009) Intersession repeatability of contrast sensitivity scores in age-related macular degeneration. Invest Ophthalmol Vis Sci 50:2621–2625PubMedCrossRef Patel PJ, Chen FK, Rubin GS, Tufail A (2009) Intersession repeatability of contrast sensitivity scores in age-related macular degeneration. Invest Ophthalmol Vis Sci 50:2621–2625PubMedCrossRef
13.
Zurück zum Zitat Patel PJ, Chen FK, Da Cruz L, Rubin GS, Tufail A (2011) Test-retest variability of reading performance metrics using MNREAD in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52:3854–3859PubMedCrossRef Patel PJ, Chen FK, Da Cruz L, Rubin GS, Tufail A (2011) Test-retest variability of reading performance metrics using MNREAD in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52:3854–3859PubMedCrossRef
14.
Zurück zum Zitat Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, Roberts C, Shoukri M, Streiner DL (2011) Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol 64:96–106PubMedCrossRef Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, Roberts C, Shoukri M, Streiner DL (2011) Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol 64:96–106PubMedCrossRef
15.
Zurück zum Zitat Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39(5):367–374PubMedCrossRef Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39(5):367–374PubMedCrossRef
16.
Zurück zum Zitat Carkeet A (2001) Modeling logMAR visual acuity scores: effects of termination rules and alternative forced-choice options. Optom Vis Sci 78:529–538PubMedCrossRef Carkeet A (2001) Modeling logMAR visual acuity scores: effects of termination rules and alternative forced-choice options. Optom Vis Sci 78:529–538PubMedCrossRef
17.
Zurück zum Zitat Elliott DB, Sanderson K, Conkey A (1990) The reliability of the Pelli-Robson contrast sensitivity chart. Ophthalmic Physiol Opt 10:21–24PubMedCrossRef Elliott DB, Sanderson K, Conkey A (1990) The reliability of the Pelli-Robson contrast sensitivity chart. Ophthalmic Physiol Opt 10:21–24PubMedCrossRef
18.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical method for assessing agreement between two methods of clinical measurement. Lancet i:307–310CrossRef Bland JM, Altman DG (1986) Statistical method for assessing agreement between two methods of clinical measurement. Lancet i:307–310CrossRef
19.
Zurück zum Zitat British Standards Institution (1979) Precision of test methods, part 1: guide for the determination of repeatability and reproducibility for a standard test method. BS 5497, Part 1. BSI, London British Standards Institution (1979) Precision of test methods, part 1: guide for the determination of repeatability and reproducibility for a standard test method. BS 5497, Part 1. BSI, London
20.
Zurück zum Zitat Tulving E, Gold C (1963) Stimulus information and contextual information as determinants of tachistoscopic recognition of words. J Exp Psychol 66:319–327PubMedCrossRef Tulving E, Gold C (1963) Stimulus information and contextual information as determinants of tachistoscopic recognition of words. J Exp Psychol 66:319–327PubMedCrossRef
21.
Zurück zum Zitat Doris N, Hart PM, Chakravarthy U, McCleland J, Stevenson M, Hudson C, Jackson J (2001) Relation between macular morphology and visual function in patients with choroidal neovascularisation of age-related macular degeneration. Br J Ophthalmol 85:184–188PubMedCrossRef Doris N, Hart PM, Chakravarthy U, McCleland J, Stevenson M, Hudson C, Jackson J (2001) Relation between macular morphology and visual function in patients with choroidal neovascularisation of age-related macular degeneration. Br J Ophthalmol 85:184–188PubMedCrossRef
22.
Zurück zum Zitat Kiser AK, Mladenovich D, Eshraghi F, Bourdeau D, Dagnelie G (2005) Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease. Optom Vis Sci 82(11):946–954PubMedCrossRef Kiser AK, Mladenovich D, Eshraghi F, Bourdeau D, Dagnelie G (2005) Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease. Optom Vis Sci 82(11):946–954PubMedCrossRef
23.
Zurück zum Zitat Blackhurst DW, Maguire MG (1989) Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study Group. Retina 9(3):163–169PubMedCrossRef Blackhurst DW, Maguire MG (1989) Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study Group. Retina 9(3):163–169PubMedCrossRef
Metadaten
Titel
Repeatability of visual function measures in age-related macular degeneration
verfasst von
Tariq Aslam
Sajjad Mahmood
Konstantinos Balaskas
Niall Patton
Rajeev G. Tanawade
Shi Zhuan Tan
Stephen A. Roberts
Jeremy Parkes
Paul N. Bishop
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2014
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-013-2421-5

Weitere Artikel der Ausgabe 2/2014

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2014 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.